296 related articles for article (PubMed ID: 9003047)
1. Regulation of delta-opioid receptor mRNA levels by receptor-mediated and direct activation of the adenylyl cyclase-protein kinase A pathway.
Buzas B; Rosenberger J; Cox BM
J Neurochem; 1997 Feb; 68(2):610-5. PubMed ID: 9003047
[TBL] [Abstract][Full Text] [Related]
2. Modulation by calcium/calmodulin-dependent protein kinase II of functional response of delta opioid receptor in neuroblastoma x glioma hybrid (NG108-15) cells.
Fan GH; Zhang WB; Yao CP; Pei G
Neuropharmacology; 1997; 36(11-12):1763-9. PubMed ID: 9517449
[TBL] [Abstract][Full Text] [Related]
3. Opioid regulation of the mouse delta-opioid receptor expressed in human embryonic kidney 293 cells.
Bot G; Blake AD; Li S; Reisine T
Mol Pharmacol; 1997 Aug; 52(2):272-81. PubMed ID: 9271350
[TBL] [Abstract][Full Text] [Related]
4. Regulation of adenylyl cyclase, ERK1/2, and CREB by Gz following acute and chronic activation of the delta-opioid receptor.
Tso PH; Yung LY; Wong YH
J Neurochem; 2000 Apr; 74(4):1685-93. PubMed ID: 10737627
[TBL] [Abstract][Full Text] [Related]
5. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
[TBL] [Abstract][Full Text] [Related]
6. Opioid receptor and calcium channel regulation of adenylyl cyclase, modulated by GM1, in NG108-15 cells: competitive interactions.
Wu G; Lu ZH; Alfinito P; Ledeen RW
Neurochem Res; 1997 Oct; 22(10):1281-9. PubMed ID: 9342733
[TBL] [Abstract][Full Text] [Related]
7. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
Law PY; Bergsbaken C
J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
[TBL] [Abstract][Full Text] [Related]
8. delta-Opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma x glioma NG108-15 hybrid cells.
Law PY; Loh HH
Mol Pharmacol; 1993 May; 43(5):684-93. PubMed ID: 8388986
[TBL] [Abstract][Full Text] [Related]
9. Opioid and cannabinoid receptor inhibition of adenylyl cyclase in brain.
Childers SR; Fleming L; Konkoy C; Marckel D; Pacheco M; Sexton T; Ward S
Ann N Y Acad Sci; 1992 Jun; 654():33-51. PubMed ID: 1321574
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation by butyrate and dibutyryl cyclic AMP of delta-opioid, alpha 2-adrenergic, and muscarinic cholinergic receptors in NCB-20 cells.
Zhu XZ; Chuang DM
J Neurochem; 1988 Jan; 50(1):17-26. PubMed ID: 2826684
[TBL] [Abstract][Full Text] [Related]
11. Altered adenylyl cyclase responsiveness subsequent to point mutations of Asp 128 in the third transmembrane domain of the delta-opioid receptor.
Cavalli A; Babey AM; Loh HH
Neuroscience; 1999; 93(3):1025-31. PubMed ID: 10473267
[TBL] [Abstract][Full Text] [Related]
12. Cyclic AMP accumulation alters calmodulin localization in SK-N-SH human neuroblastoma cells.
Mangels LA; Gnegy ME
Brain Res Mol Brain Res; 1992 Jan; 12(1-3):103-10. PubMed ID: 1347631
[TBL] [Abstract][Full Text] [Related]
13. Effects of C-terminal truncation of the recombinant delta-opioid receptor on phospholipase C and adenylyl cyclase coupling.
Hirst RA; Smart D; Devi LA; Lambert DG
J Neurochem; 1998 Jun; 70(6):2273-8. PubMed ID: 9603191
[TBL] [Abstract][Full Text] [Related]
14. Chronic activation of inhibitory delta-opioid receptors cross-regulates the stimulatory adenylate cyclase-coupled prostaglandin E1 receptor system in neuroblastoma x glioma (NG108-15) hybrid cells.
Ammer H; Schulz R
J Neurochem; 1995 Jun; 64(6):2449-57. PubMed ID: 7760024
[TBL] [Abstract][Full Text] [Related]
15. Orphanin FQ/nociceptin and mu-opioid receptor mRNA levels in human SH-SY5Y neuroblastoma cells: effects of activating the cAMP-PKA signal transduction pathway.
Wallington CL; Peters DM; Gelb CR; Peterfreund RA
Brain Res; 2002 Jul; 944(1-2):73-81. PubMed ID: 12106667
[TBL] [Abstract][Full Text] [Related]
16. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse.
Narita M; Mizoguchi H; Kampine JP; Tseng LF
Br J Pharmacol; 1996 Aug; 118(7):1829-35. PubMed ID: 8842450
[TBL] [Abstract][Full Text] [Related]
17. Heterologous sensitization of adenylate cyclase is protein kinase A-dependent in Cath.a differentiated (CAD)-D2L cells.
Johnston CA; Beazely MA; Vancura AF; Wang JK; Watts VJ
J Neurochem; 2002 Sep; 82(5):1087-96. PubMed ID: 12358756
[TBL] [Abstract][Full Text] [Related]
18. Determination of delta-opioid in NG108-15 cells.
Ho BY; Holmes BB; Zhao J; Fujimoto J
Eur J Pharmacol; 1997 Jan; 319(1):109-14. PubMed ID: 9030905
[TBL] [Abstract][Full Text] [Related]
19. Suppression of phospholipase C blocks Gi-mediated inhibition of adenylyl cyclase activity.
Fan GH; Zhou TH; Zhang WB; Pei G
Eur J Pharmacol; 1998 Jan; 341(2-3):317-22. PubMed ID: 9543254
[TBL] [Abstract][Full Text] [Related]
20. Identification of the critical domains of the delta-opioid receptor involved in G protein coupling using site-specific synthetic peptides.
Merkouris M; Dragatsis I; Megaritis G; Konidakis G; Zioudrou C; Milligan G; Georgoussi Z
Mol Pharmacol; 1996 Oct; 50(4):985-93. PubMed ID: 8863845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
